In the treatment group and the control group , there was no improvement in the liver B ultrasonic classification 3 months and 6 months after the therapy ( P > 0.05 ) ; however , in 9 months and 12 months , the liver B ultrasonic classification in the treatment group was better than that in the control group ( P < 0.05 , P < 0.01 , respectively ) .